TABLE 1.

Drugs used in the treatment of Idiopathic pulmonary fibrosis (IPF).

Drugs	Mechanism of action	References
Pirfenidone	Anti-fibrotic drug	Nathan et al. (2019)
Nintedanib	Anti-PDGFR, VEGFR, FGFR drug	Flaherty et al. (2019), Makino (2021)
Pamrevlumab	Anti-CTGF antibody	Richeldi et al. (2020)
GSK3008348	αvβ6 antagonist	John et al. (2020)
sildenafil	phosphodiesterase-5 inhibitor	Kang & Song, (2021)
Co-trimoxazole or doxycycline	Antimicrobial drug	Wilson et al. (2020)
Lebrikizumab	Anti-IL13	Maher et al. (2021b)
Carlumab	Anti-CCL2	Raghu et al. (2015)
Simtuzumab	Anti-LOX antibody	Raghu et al. (2017)